531173 Stock Overview Manufactures and sells active pharmaceuticals ingredients (API), intermediates, bulk drugs, and specialty chemicals in India. More details
Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Add noteSyschem (India) Limited Competitors Price History & Performance
Summary of share price highs, lows and changes for Syschem (India) Historical stock prices Current Share Price ₹49.08 52 Week High ₹73.90 52 Week Low ₹37.16 Beta -0.71 1 Month Change 25.78% 3 Month Change 15.10% 1 Year Change -6.55% 3 Year Change 190.41% 5 Year Change 643.64% Change since IPO 255.65%
Recent News & Updates
New minor risk - Share price stability Dec 20
Second quarter 2025 earnings released Nov 09
Syschem (India) Limited to Report Q3, 2025 Results on Nov 08, 2024 Oct 28
Less than half of directors are independent Sep 25
First quarter 2025 earnings released: EPS: ₹0.03 (vs ₹0.44 in 1Q 2024) Aug 13
Syschem (India) Limited Approves Appointment of Vivek Trehan as (Non-Executive) Director Aug 09 See more updates
New minor risk - Share price stability Dec 20
Second quarter 2025 earnings released Nov 09
Syschem (India) Limited to Report Q3, 2025 Results on Nov 08, 2024 Oct 28
Less than half of directors are independent Sep 25
First quarter 2025 earnings released: EPS: ₹0.03 (vs ₹0.44 in 1Q 2024) Aug 13
Syschem (India) Limited Approves Appointment of Vivek Trehan as (Non-Executive) Director Aug 09
Investor sentiment improves as stock rises 15% Jul 31
Syschem (India) Limited to Report Q1, 2025 Results on Aug 12, 2024 Jul 25
Full year 2024 earnings released: EPS: ₹0.78 (vs ₹1.53 in FY 2023) Jul 08
Syschem (India) Limited, Annual General Meeting, Aug 07, 2024 Jul 04
Syschem (India) Limited Announces Resignation of Neena Batra as Non Executive, Director Jun 27
Syschem (India) Limited to Report Q4, 2024 Results on May 06, 2024 Apr 29
Investor sentiment improves as stock rises 16% Apr 03
Third quarter 2024 earnings released: EPS: ₹0.06 (vs ₹0.67 in 3Q 2023) Feb 10
Syschem (India) Limited to Report Q3, 2024 Results on Feb 09, 2024 Jan 29
Investor sentiment improves as stock rises 19% Jan 08
New minor risk - Profit margin trend Nov 13
Second quarter 2024 earnings released: EPS: ₹0.35 (vs ₹0.48 in 2Q 2023) Nov 13
Investor sentiment improves as stock rises 17% Nov 02
Syschem (India) Limited to Report Q2, 2024 Results on Nov 06, 2023 Nov 01
Investor sentiment improves as stock rises 16% Sep 27
Investor sentiment improves as stock rises 17% Aug 21
Syschem (India) Limited, Annual General Meeting, Sep 23, 2023 Aug 05
Investor sentiment improves as stock rises 19% Aug 03
New minor risk - Share price stability Aug 01
Syschem (India) Limited to Report Q1, 2024 Results on Aug 04, 2023 Jul 29
New major risk - Earnings quality Jun 08
Full year 2023 earnings released: EPS: ₹0.14 (vs ₹0.76 loss in FY 2022) Jun 08
Investor sentiment improves as stock rises 16% May 11
Syschem (India) Limited to Report Q4, 2023 Results on May 15, 2023 May 07
Third quarter 2023 earnings released: EPS: ₹0.67 (vs ₹0.43 loss in 3Q 2022) Jan 23
Syschem (India) Limited Announces Board Resignations Jan 21
Syschem (India) Limited to Report Q3, 2023 Results on Jan 20, 2023 Jan 12
Insider recently sold ₹193k worth of stock Dec 20 Syschem (India) Limited announced a financing transaction Dec 14
Insufficient new directors Dec 02
Whole-Time Director recently sold ₹4.5m worth of stock Nov 29
Syschem (India) Limited to Report Q2, 2023 Results on Nov 02, 2022 Oct 28
Non-Executive Non-Independent Director recently sold ₹282k worth of stock Sep 01
Syschem (India) Limited, Annual General Meeting, Sep 16, 2022 Aug 20
First quarter 2023 earnings released: EPS: ₹0.56 (vs ₹0.69 loss in 1Q 2022) Jul 28
Syschem (India) Limited to Report Q1, 2023 Results on Jul 27, 2022 Jul 19 Syschem (India) Limited announced that it has received INR 85.25 million in funding Jun 28
Chief Financial Officer recently sold ₹112k worth of stock Jun 13
Full year 2022 earnings released: ₹0.76 loss per share (vs ₹2.70 loss in FY 2021) Jun 03 Syschem (India) Limited announced that it expects to receive INR 85.25 million in funding May 21
Syschem (India) Limited to Report Q4, 2022 Results on May 27, 2022 May 20
Syschem (India) Limited to Report Q4, 2022 Results on May 27, 2022 May 19 Syschem (India) Limited Announces Managing Director Changes
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Feb 11
Second quarter 2022 earnings released: ₹0.74 loss per share (vs ₹0.47 loss in 2Q 2021) Nov 12
Full year 2021 earnings released: ₹2.58 loss per share (vs ₹0.99 loss in FY 2020) Jul 04
Third quarter 2021 earnings released: ₹0.72 loss per share (vs ₹0.84 loss in 3Q 2020) Feb 10
New 90-day high: ₹8.33 Feb 06
Syschem (India) Limited to Report Q3, 2021 Results on Feb 08, 2021 Jan 27
New 90-day high: ₹7.78 Jan 08
New 90-day high: ₹7.27 Dec 14
Syschem (India) Limited Appoints Shikha Kataria as Company Secretary and Compliance Officer Nov 18
Syschem (India) Limited Announces Resignation of Amarjeet Kaur as Company Secretary and Compliance Officer Nov 12
Syschem (India) Limited Announces Board Changes Nov 06
First half earnings released Nov 01
New 90-day low - ₹5.81 Aug 20
New 90-day low - ₹5.86 Jul 27
Syschem (India) Limited to Report Q1, 2021 Results on Jul 27, 2020 Jul 26 Shareholder Returns 531173 IN Pharmaceuticals IN Market 7D -6.5% 3.1% 0.5% 1Y -6.5% 36.2% 17.4%
See full shareholder returns
Return vs Market: 531173 underperformed the Indian Market which returned 17.4% over the past year.
Price Volatility Is 531173's price volatile compared to industry and market? 531173 volatility 531173 Average Weekly Movement 8.2% Pharmaceuticals Industry Average Movement 5.9% Market Average Movement 6.2% 10% most volatile stocks in IN Market 9.0% 10% least volatile stocks in IN Market 4.1%
Stable Share Price: 531173's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: 531173's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company Syschem (India) Limited manufactures and sells active pharmaceuticals ingredients (API), intermediates, bulk drugs, and specialty chemicals in India. The company’s APIs/intermediates include amoxycillin trihydrate, ampicillin trihydrate, cloxacillin sodium, dicloxacillin sodium, flucloxacillin sodium, cephalexin, and cefadroxil. It also engages in the distillation of specialty solvents, such as DMF, acetonitrile, ethyl acetate, and THF; and contract manufacturing business.
Show more Syschem (India) Limited Fundamentals Summary How do Syschem (India)'s earnings and revenue compare to its market cap? 531173 fundamental statistics Market cap ₹1.96b Earnings (TTM ) -₹5.35m Revenue (TTM ) ₹2.96b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 531173 income statement (TTM ) Revenue ₹2.96b Cost of Revenue ₹2.34b Gross Profit ₹619.75m Other Expenses ₹625.11m Earnings -₹5.35m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) -0.13 Gross Margin 20.94% Net Profit Margin -0.18% Debt/Equity Ratio 0.2%
How did 531173 perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/01/02 18:44 End of Day Share Price 2025/01/02 00:00 Earnings 2024/09/30 Annual Earnings 2024/03/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Syschem (India) Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.